共 50 条
- [21] A Systematic Review of Compliance with Palivizumab Administration for RSV ImmunoprophylaxisJOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (01): : 46 - 58Frogel, Michael P.Stewart, Dan L.Hoopes, MichaelFernandes, Ancilla W.Mahadevia, Parthiv J.
- [22] Konsensuspapier zur Prophylaxe der RSV-Infektion mit Palivizumab und Post-RSV-AtemwegserkrankungConsensus paper on prophylaxis against RSV infection with Palivizumab and post-RSV respiratory tract disease Monatsschrift Kinderheilkunde Zeitschrift für Kinder- und Jugendmedizin, 2008, 156 : 381 - 383
- [23] Use of palivizumab for prevention of respiratory syncytial virus (RSV) in the New York State (NYS) Medicaid population.PHARMACOTHERAPY, 2016, 36 (07): : E98 - E99Reilly, IreneRogler, BarbaraDunn, TerryCoe, HollyGibson, WalterFeuerstein, Steve
- [24] A High Titer Anti RSV Polyclonal Antibody (RI-002) Prevents Infection with Palivizumab Resistant (PR) RSV in Cotton Rats and Achieves Greater Neutralizing RSV Activity As Compared to PalivizumabJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB165 - AB165Mond, James J.Gilbert, Brian
- [25] Passive immunisation of preterm infants with palivizumab against RSV infectionJOURNAL OF INFECTION, 2006, 52 (01) : 2 - 8Harkensee, CBrodlie, MEmbleton, NDMckean, M
- [26] AAP Issues Updated Guidance on Palivizumab Prophylaxis for RSV InfectionAMERICAN FAMILY PHYSICIAN, 2014, 90 (12) : 867 - 868Lambert, Mara
- [27] Palivizumab -: MEDI-493 -: Synagis® -: Anti-RSVDRUGS OF THE FUTURE, 2000, 25 (09) : 981 - 981不详
- [30] Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of PalivizumabPEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (12) : E290 - E297Chan, ParcoLi, AbbyPaes, BoscoAbraha, HabenMitchell, IanLanctot, Krista L.